Skip to main content
IAS 2023

Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV

pattern

IAS – the International AIDS Society – and its partners are organizing a one-day pre-meeting, titled “Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV”, in conjunction with IAS 2023, the 12th IAS Conference on HIV Science.

View the session recordings here.

alternative text

The event is at capacity and registration is closed. Add your name to the waiting list by emailing [email protected]. Waitlisted delegates are encouraged to be at the venue by 08:30 AEST on 22 July 2023. We will make a decision on whether there is sufficient space for them to enter the venue by 08:50 AEST.

The event will be held at the Pullman & Mercure King George Square Hotel, Corner of Ann & Roma Street, Brisbane, 4000, Australia, on 22 July 2023. The content will be accessible online after the pre-meeting.  

This pre-meeting will be of interest to HIV basic scientists, clinicians, researchers, public health practitioners, implementers, community advocates and those working towards preventing and managing HPV-related cancers. 

Objective

The objective of the meeting is to bring together a diverse group of scientific, technical and community representatives to discuss current opportunities and challenges for increased prevention and screening for HPV, as well as diagnosis and treatment of intraepithelial neoplasia to prevent cervical cancer and anal cancer in people living with HIV and other populations.

Programme committee

  • Adeeba Kamarulzaman, Monash University, Malaysia
  • Andrew Grulich, Kirby Institute, University of NSW, Australia
  • Azadeh Baghaki, Unitaid, Switzerland
  • Joel Palefsky, University of California San Francisco, United States
  • Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa

Featured speakers

Salome Agallo

Salome Agallo

NCD Alliance, Kenya

View
Karen Canfell

Karen Canfell

The Daffodil Centre, Cancer Council NSW and the University of Sydney, Australia

View
Richard Hillman

Richard Hillman

St Vincent's Hospital, Australia

View
Joel Palefsky

Joel Palefsky

University of California San Francisco School of Medicine, United States

View
Meg Doherty

Meg Doherty

World Health Organization, Switzerland

View

Programme

08:00 – 09:00 Registration open (coffee and tea provided)
09:00 – 10:00 Session 1 – The scale of the challenges
Chair: Adeeba Kamarulzaman, Monash University, Malaysia
09:00 – 09:05 Acknowledgement of country and welcome

Andrew Grulich, Kirby Institute, UNSW, Australia

09:05 – 09:10 Introduction

Adeeba Kamarulzaman, Monash University, Malaysia

09:10 – 09:25 Pre-recorded
My journey of survival and my mission to advocate for integrated services
Salome Agallo, NCD Alliance, Kenya
09:25 – 09:45 Keynote
HPV-related cancers: Burden, WHO recommendations, progress and opportunities for integration
Meg Doherty, WHO, Switzerland
09:45 – 09:50 Pre-recorded
Unitaid’s contribution to accelerating elimination of cervical cancer in low-resource settings
Azadeh Baghaki, Unitaid, Switzerland
09:50 – 10:00 Making the investment case to catalyze HPV-related cancer prevention and treatment Karen Canfell, The Daffodil Centre, Cancer Council NSW and the University of Sydney, Australia
10:00 – 10:30 Break (coffee, tea and morning snack provided)
10:30 – 12:00 Session 2 – State of the art guidance for HPV vaccination, screen and treat
Chair: Andrew Grulich, Kirby Institute UNSW, Australia
10:30 – 10:50 HPV vaccination Sinead Delany-Moretlwe, Wits RHI, South Africa
10:50 – 11:10 Pre-recorded
Cervical cancer screen, triage and treatment
Maribel Almonte, WHO, Switzerland
11:10 – 11:30 Anal cancer screen and treatment Joel Palefsky, University of California San Francisco, United States
11:30 – 12:00 General discussion of session 1 and 2 Moderated by Andrew Grulich, Kirby Institute UNSW, Australia
12:00 – 13:00 Lunch (hot and cold lunch options provided)
13:00 – 14:30 Session 3 – Good-practice models for HPV-related cancer elimination
Chair: Sinead Delany-Moretlwe, Wits RHI, South Africa
13:00 – 13:10 Pre-recorded
Latest evidence from the KEN-SHE study
Nelly Mugo, Kenya Medical Research Institute, Kenya
13:10 – 13:20 Scaling up access to cervical screening in Malaysia: the ROSE Foundation approach Marion Saville, Australian Centre for the Prevention of Cervical Cancer, Australia
13:20 – 13:30 Eliminating cervical cancer in the western Pacific Andrew Vallely, Kirby Institute UNSW, Australia
13:30 – 13:40 SUCCESS – Scale up cervical cancer elimination with secondary prevention strategy Eric Fleutelot, Expertise France, France
13:40 – 13:50 Scaling up HPV testing and portable thermal ablation devices in Kenya Lance Osiro, CHAI, Kenya
13:50 – 14:00 Anal cancer programme for gay men and other men who have sex with men in Nigeria Rebecca Nowak, University of Maryland Baltimore, United States
14:00 – 14:10 Towards an anal cancer screening algorithm Mary Poynten, Kirby Institute UNSW, Australia
14:10 – 14:30 General discussion
14:30 – 15:00 Break (coffee, tea and afternoon snack provided)
15:00 – 15:45 Session 4 – Current and future research gaps
Chair: Joel Palefsky, University of California San Francisco, United States
15:00 – 15:45 Panel discussion
Current and future research gaps related to ending HPV-related cancers especially for people living with or affected by HIV

Richard Hillman, St Vincent’s Hospital, Australia

Sinead Delany-Moretlwe, Wits RHI, South Africa

Karen Canfell, The Daffodil Centre, Cancer Council NSW and the University of Sydney, Australia

Morkor Newman Owiredu, WHO, Switzerland

Andrew Doupe, Unitaid Community Engagement Consultant, Australia

15:45 – 16:00 Break (no additional catering provided)
16:00 – 17:00 Session 5 – Call to action
Chair: Adeeba Kamarulzaman, Monash University, Malaysia
16:00 – 16:10 Keynote
Global Fund perspectives on the financing and integration of HPV-related cancer prevention and treatment with HIV services
Roslyn Morauta, Global Fund, Switzerland
16:10 – 17:00 Panel discussion

Commitments to ensure ending cervical cancer by 2030 in all countries and all populations.

What would it take to commit to ending all HPV-related cancers by 2030 among people living with or affected by HIV?

Meg Doherty, WHO, Switzerland

Cordelia Katureebe, Ministry of Health, Uganda

Lucas de Toca, Department of Foreign Affairs and Trade, Australia

Roslyn Morauta, Global Fund, Switzerland

Jane Costello, Positive Life NSW, Australia

Paulus Ripa, Western Highlands Provincial Health Authority, Papua New Guinea

17:00 – 18:00 Networking reception

Sign up to participate

To encourage the broadest participation in the pre-meeting, attendance will be free. However, the meeting will be in person only and limited to 250 attendees. Please note you may only sign up for one IAS 2023 pre-meeting.

Event at capacity and registration is closed. Add your name to the waiting list by emailing [email protected].

Please note that signing up for the pre-meeting does not grant you access to IAS 2023; a separate registration is required for the main event.

See full event description here.

 

Proudly supported by major donor and organizing partner:

Unitaid logo

With support from bronze sponsor:

CSL Seqirus logo

With support from:

PCC logoNCD Alliance logoCepheid Care logo

pattern